While we did not find evidence for SETD2 promoter hypermethylation in this study (data not shown, consistent with [57]), other regulators of H3K36 methylation like NSD1 can be targeted in this way in ccRCC [58]. Here, SETD2 is linked to nonpapillary renal cell carcinoma.